Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Internal Medicine (Tokyo, Japan)|May 29, 2007
Effects of dietary iron reduction versus phlebotomy in patients with chronic hepatitis C: results from a randomized, controlled trial on 40 Japanese patientsYoshio Sumida, Kazuyuki Kanemasa, Kohei Fukumoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2007
Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in Japanese patients with chronic hepatitis CYoshio Sumida, Kazuyuki Kanemasa, Kohei Fukumoto, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 6, 2007
[Utility of a little phlebotomy intermittently just before intravenous injection of glycyrrhizin for patients with chronic hepatitis C]Yoshio Sumida, Kazuyuki Kanemasa, Kohei Fukumoto, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver diseaseMasato Yoneda, Emmanuel Thomas, Yoshio Sumida, et al.
Expert Opinion on Pharmacotherapy|April 3, 2020
Current and new pharmacotherapy options for non-alcoholic steatohepatitisYoshio Sumida, Masato Yoneda, Yuji Ogawa, et al.
Journal of Gastroenterology|December 9, 2024
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert reviewYoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapyTakeshi Okanoue, Masahito Minami, Akiko Makiyama, et al.
Journal of Clinical Medicine|April 17, 2020
Sequential Combination of FIB-4 Followed by M2BPGi Enhanced Diagnostic Performance for Advanced Hepatic Fibrosis in an Average Risk PopulationMimi Kim, Dae Won Jun, Huiyul Park, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 7, 2014
[Progress in treatment and study of NAFLD. Discussion]Goshi Shiota, Hirofumi Uto, Masafumi Ono, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 22, 2020
Hepatocellular carcinoma and other complications of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A structured review of published worksYuichiro Eguchi, Gabriel Wong, I-Heng Lee, et al.
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Internal Medicine (Tokyo, Japan)|May 29, 2007
Effects of dietary iron reduction versus phlebotomy in patients with chronic hepatitis C: results from a randomized, controlled trial on 40 Japanese patientsYoshio Sumida, Kazuyuki Kanemasa, Kohei Fukumoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2007
Correlation of hepatic steatosis with body mass index, serum ferritin level and hepatic fibrosis in Japanese patients with chronic hepatitis CYoshio Sumida, Kazuyuki Kanemasa, Kohei Fukumoto, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 6, 2007
[Utility of a little phlebotomy intermittently just before intravenous injection of glycyrrhizin for patients with chronic hepatitis C]Yoshio Sumida, Kazuyuki Kanemasa, Kohei Fukumoto, et al.
Hepatology (Baltimore, Md.)|March 4, 2014
The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver diseaseMasato Yoneda, Emmanuel Thomas, Yoshio Sumida, et al.
Expert Opinion on Pharmacotherapy|April 3, 2020
Current and new pharmacotherapy options for non-alcoholic steatohepatitisYoshio Sumida, Masato Yoneda, Yuji Ogawa, et al.
Journal of Gastroenterology|December 9, 2024
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert reviewYoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapyTakeshi Okanoue, Masahito Minami, Akiko Makiyama, et al.
Journal of Clinical Medicine|April 17, 2020
Sequential Combination of FIB-4 Followed by M2BPGi Enhanced Diagnostic Performance for Advanced Hepatic Fibrosis in an Average Risk PopulationMimi Kim, Dae Won Jun, Huiyul Park, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 7, 2014
[Progress in treatment and study of NAFLD. Discussion]Goshi Shiota, Hirofumi Uto, Masafumi Ono, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 22, 2020
Hepatocellular carcinoma and other complications of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A structured review of published worksYuichiro Eguchi, Gabriel Wong, I-Heng Lee, et al.
Pageof 22